medigraphic.com
ISSN 0028-3851 (Print)

2023, Number 2

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2023; 51 (2)

Immunoglobulins and multiple sclerosis

Colorado OH, Tenorio GVG

Language: Spanish
References: 3
Page: 58-59
PDF size: 101.86 Kb.





REFERENCES

  1. Morales-Ruiz V, Juárez-Vaquera VH, Rosetti-Sciutto M, Sánchez-Muñoz F, Adalid-Peralta L. Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis. Autoimmun Rev. 2022; 21 (3): 103019. doi: 10.1016/j.autrev.2021.103019.

  2. Achiron A, Miron S. Intravenous immunoglobulin and multiple sclerosis. Clin Rev Allergy Immunol. 2005; 29 (3): 247-254. doi: 10.1385/CRIAI:29:3:247.

  3. Rosa GR, O'Brien AT, Nogueira EAG, Carvalho VM, Paz SC, Fragoso YD. There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis. Arq Neuropsiquiatr. 2018; 76 (6): 361-366. doi: 10.1590/0004-282X20180041.




2020     |     www.medigraphic.com